Literature DB >> 6499206

Studies of the biochemical and immunological properties of human neutrophil alkaline phosphatase with comparison to the established alkaline phosphatase isoenzymes.

G P Smith, H Harris, T J Peters.   

Abstract

A range of affinity column chromatographic procedures and various inhibitors have been used to compare human neutrophil alkaline phosphatase with the three established isoenzymes. The column chromatography studies have clearly distinguished neutrophil alkaline phosphatase from the intestinal isoenzyme. Inhibition studies with L-phenylalanine, L-homoarginine and levamisole have revealed a distinct pattern of inhibition for liver, kidney and neutrophil alkaline phosphatase which is quite different from the pattern shown by placental and intestinal alkaline phosphatase. Immunospecificity experiments with a monoclonal antibody raised to human liver alkaline phosphatase have shown that it cross reacts with alkaline phosphatase from kidney, bone and neutrophil. In all studies, neutrophil alkaline phosphatase has virtually identical properties to that of liver, kidney and bone alkaline phosphatase. This is strong evidence that neutrophil alkaline phosphatase is a product of the same structural gene which codes for the liver/bone/kidney group of human alkaline phosphatases.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6499206     DOI: 10.1016/0009-8981(84)90380-2

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  3 in total

Review 1.  Interplay between intestinal alkaline phosphatase, diet, gut microbes and immunity.

Authors:  Mehrbod Estaki; Daniella DeCoffe; Deanna L Gibson
Journal:  World J Gastroenterol       Date:  2014-11-14       Impact factor: 5.742

2.  Neutrophil alkaline phosphatase activity increase in bacterial infections is not associated with a general increase in secretory vesicle membrane components.

Authors:  A Karlsson; L Khalfan; C Dahlgren; T Stigbrand; P Follin
Journal:  Infect Immun       Date:  1995-03       Impact factor: 3.441

3.  Intestinal anti-inflammatory activity of Ground Cherry (Physalis angulata L.) standardized CO2 phytopharmaceutical preparation.

Authors:  Luiz Domingues Almeida Junior; Ana Elisa Valencise Quaglio; Celso Acácio Rodrigues de Almeida Costa; Luiz Claudio Di Stasi
Journal:  World J Gastroenterol       Date:  2017-06-28       Impact factor: 5.742

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.